Provided by Tiger Trade Technology Pte. Ltd.

Scholar Rock Holding Corp

55.41
-0.2600-0.47%
Post-market: 61.976.56+11.84%19:59 EDT
Volume:994.40K
Turnover:55.26M
Market Cap:6.75B
PE:-16.49
High:56.94
Open:55.67
Low:54.91
Close:55.67
52wk High:61.76
52wk Low:27.07
Shares:121.79M
Float Shares:107.73M
Volume Ratio:0.82
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3601
EPS(LYR):-3.4845
ROE:-167.77%
ROA:-58.82%
PB:26.59
PE(LYR):-15.90

Loading ...

Scholar Rock Holding Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Scholar Rock Files for up to $200 Million At-the-Market Stock Offering

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06

Earnings Flash (SRRK) Scholar Rock Posts Q2 Loss of $0.84 a Share, vs. FactSet Est of $0.84 Loss

MT Newswires Live
·
Aug 06

Stock Track | Scholar Rock Holding Soars 9.71% in Pre-market After Q2 Earnings Beat Estimates

Stock Track
·
Aug 06

Scholar Rock Holding Q2 EPS $(0.84) Beats $(0.85) Estimate; Cash Balance Of $492M

Benzinga Earnings
·
Aug 06

\tScholar Rock Holding Scholar Rock Holding Q2 Net Income USD -109.896 Million

Reuters
·
Aug 06

\tSCHOLAR Rock Holding Q2 EPS Usd -0.84

THOMSON REUTERS
·
Aug 06

Earning Preview: Scholar Rock Holding Corp Q2 revenue is expected to be flat, institutional views tilt cautious

Earnings Agent
·
Jul 31

Scholar Rock to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Jul 29

Netherlands' Argenx Q2 Net Sales Rise

Reuters
·
Jul 23

Scholar Rock Holding Price Target Maintained with a $58.00/share by Wedbush

Dow Jones
·
Jul 21

Switzerland's Novartis Beats Q2 Sales Estimates on Strong Sales Across Priority Brands

Reuters
·
Jul 21

Sweden's Medcap Q2 Net Sales Rise 16% on Organic Growth and Acquisitions

Reuters
·
Jul 21

Scholar Rock Says EU Opinion on SMA Drug May be Pushed to Later in 2026

Reuters
·
Jul 20

Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA

TIPRANKS
·
Jul 20

Scholar Rock Announces Press Release on Apitegromab CHMP Opinion Timing for SMA MAA

Reuters
·
Jul 20

Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (chmp) Opinion for Apitegromab Marketing Authorisation Application (maa) for Spinal Muscular Atrophy (sma)

THOMSON REUTERS
·
Jul 20

Scholar Rock Holding Corp - Apitegromab Chmp Opinion Expected After Catalent Indiana Classification or Second Facility Inclusion

THOMSON REUTERS
·
Jul 20

Scholar Rock Holding Corp - Apitegromab Bla Under FDA Review with Sept 30, 2026 Pdufa Date

THOMSON REUTERS
·
Jul 20